Benign Disease
Conditions
Keywords
Children, Allogeneic bone marrow transplantation, Intestinal damage, Citrulline, Graft versus Host Disease, 0 to 18 years old
Brief summary
determine the interest of the dosage of citrullinemia to monitor the bowel damage after allogeneic bone marrow transplantation in children.
Detailed description
30 children included. Dosage of citrullinemia on day -7, day 0 and every week up to 100 days after BMT. Histological examination and extensive infectious screening in case of persistent digestive symptoms (more than 3 days). Two groups of patients regarding on digestive involvement. Comparison of the values of citrullinemia between these two groups.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* 0 to 18 years * allogeneic bone marrow transplantation for malignant or benign disease * affiliation to French sécurité sociale * parent's consent
Exclusion criteria
* severe gastro-intestinal involvement before transplant * previous digestive surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Citrullinemia (weekly) | weekly |
Secondary
| Measure | Time frame |
|---|---|
| Gastro-intestinal complications in children following allogeneic bone marrow transplantation | following allogenic bone marrow transplantation |
Countries
France